| # | Drug | Count |
|---|---|---|
| 0 | CABOTEGRAVIR | 5 |
| 1 | ADALIMUMAB | 4 |
| 2 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 3 |
| 3 | MEDROXYPROGESTERONE ACETATE | 3 |
| 4 | CYCLOPHOSPHAMIDE | 2 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 7 | DUPILUMAB | 2 |
| 8 | ETANERCEPT | 2 |
| 9 | EXEMESTANE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABOTEGRAVIR SODIUM | 1 | 0.0006 |
| 1 | CABOTEGRAVIR | 5 | 0.0006 |
| 2 | ACITRETIN | 1 | 0.0002 |
| 3 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 4 | CIMETIDINE | 1 | 0.0001 |
| 5 | EXEMESTANE | 2 | 0.0001 |
| 6 | TESTOSTERONE | 2 | 0.0001 |
| 7 | EMICIZUMAB | 1 | 0.0001 |
| 8 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 3 | 0.0001 |
| 9 | FLUDARABINE PHOSPHATE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen [EPC] | 2 | 0.0001 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0000 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |